Protective Effect of Andrographolide on Alleviating Chronic Alcoholic Liver Disease in Mice by Inhibiting Nuclear Factor Kappa B and Tumor Necrosis Factor Alpha Activation

다국어 초록 (Multilingual Abstract)

Much research has indicated that alcoholic liver disease (ALD) is associated with oxidative stress and inflammation induced by ethanol, and that numerous antioxidants could effectively alleviate such injuries. Moreover, recent studies have identified andrographolide (AD) as having strong anti-inflammatory and antioxidant activities, which can block oxidative damage associated with nuclear factor kappa B (NF-κB)-mediated inflammation. However, the biological role and potential mechanism of AD in its protection against ALD have not been fully characterized. To observe the possible effect of AD, male C57BL/6J mice received ethanol through intragastrical gavage for 12 weeks in this study. The ethanol group was separated into five subgroups: (1) model group (n = 10); (2) silymarin group (0.1 mg/g body weight [BW], n = 10); (3) AD (0.05 mg/g BW) group (n = 10); (4) AD (0.1 mg/g BW) group (n = 10); and (5) AD (0.2 mg/g BW) group (n = 10). Mice in AD groups were treated orally by gavage once per day. The experimental results show that serum aminotransferase, liver lipids, lipid peroxidation, and antioxidant capacities were significantly changed in the model group after alcohol treatment, and the liver tissue histological findings showed pathological changes. Compared with the model group, treatment with AD improved serum aminotransferase, liver function, lipid accumulation, and hepatic reactive oxygen species levels. And AD decreased the hepatic NF-κB and tumor necrosis factor alpha (TNF-α) protein expression of ALD mice. This research demonstrated that AD can alleviate liver pathological injury and oxidative stress in mice exposed to ethanol by decreasing the expression of NF-κB and TNF-α.

참고문헌 (Reference)

1 Graf SA, "Unhealthy alcohol use is associated with postoperative complications in veterans undergoing lung resection" 10 : 1648-1656, 2018

2 Yamamoto Y, "Therapeutic potential of inhibition of the NF-jB pathway in the treatment of inflammation and cancer" 107 : 135-142, 2001

3 Wang FS, "The global burden of liver disease: The major impact of China" 60 : 2099-2108, 2014

4 Roh YS, "TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration" 309 : G30-G41, 2015

5 Lawrence T, "Possible new role for NF-kappaB in the resolution of inflammation" 7 : 1291-1297, 2001

6 Felix Stickel, "Pathophysiology and Management of Alcoholic Liver Disease: Update 2016" 거트앤리버 소화기연관학회협의회 11 (11): 173-188, 2017

7 Loguercio C, "Oxidative stress in viral and alcoholic hepatitis" 34 : 1-10, 2003

8 Barnes PJ, "Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases" 336 : 1066-1071, 1997

9 Beier JI, "Mechanisms and cell signaling in alcoholic liver disease" 391 : 1249-1264, 2010

10 Barve S, "Interactions of cytokines, S-adenosylmethionine, and S-adenosylhomocysteine in alcohol-induced liver disease and immune suppression" 21 : S38-S42, 2006

11 Ramaiah SK, "Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury" 17 : 431-440, 2007

12 Stein E, "Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide" 65 : 998-1005, 2016

13 World Health Organization, "Global Status Report on Alcohol and Health" World Health Organization 2018

14 Liu Y, "Genetic polymorphism of two enzymes with alcoholic liver disease in Northeast China" 59 : 204-, 2012

15 Albano E, "Free radical mechanisms in immune reactions associated with alcoholic liver disease" 32 : 110-114, 2002

16 Arifullah M, "Evaluation of antibacterial and anti-oxidant potential of andrographolide and echiodinin isolated from callus culture of Andrographis paniculata Nees" 604-610, 2013

17 Thamlikitkul V, "Efficacy of Andrographis paniculata, Nees for pharyngotonsillitis in adults" 74 : 437-442, 1991

18 Singal AK, "Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status" 3 : 205-210, 2011

19 Wu XQ, "Computational and biological investigation of the soybean lecithin–gallic acid complex for ameliorating alcoholic liver disease in mice with iron overload" 10 : 5203-5214, 2019

20 Nagata K, "Common pathogenic mechanism in development progression of liver injury caused by nonalcoholic or alcoholic steatohepatitis" 32 : 453-468, 2007

21 Rossi M, "Colorectal cancer and alcohol consumption—Populations to molecules" 10 : 38-, 2018

22 Gobejishvili L, "Chronic ethanolmediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: Relevance to alcoholic liver disease" 291 : 681-688, 2006

23 Mueller S, "Caspase-cleaved K18fragments increase during alcohol withdrawal and predict liverrelated death in patients with ALD" 66 : 96-107, 2017

24 Hill DB, "Antioxidants attenuate nuclear factor-kB activation and tumor necrosis factor-a production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro" 32 : 563-570, 1999

25 Shamsuzzoha M, "Antifertility effect in mice of medicinal plant of family Acanthaceae" 312 : 900-, 1978

26 Peng S, "Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-jB pathways" 6 : 205-211, 2016

27 Xia YF, "Andrographolide attenuates inflammation by inhibition of NF-jB activation through covalent modification of reduced cysteine 62 of p50" 173 : 4207-4217, 2004

28 Liang E, "Andrographolide ameliorates diabetic cardiomyopathy in mice by blockage of oxidative damage and NFjB-mediated inflammation" 1-13, 2018

29 Yan Cui, "Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice" 대한약학회 37 (37): 1624-1633, 2014

30 Punzalan CS, "Alcoholic hepatitis and HCV interactions in the modulation of liver disease" 22 : 769-776, 2015

31 Meagher EA, "Alcohol-induced generation of lipid peroxidation products in humans" 104 : 805-813, 1999

32 Munukutla S, "Alcohol toxicity in diabetes and its complications: A double trouble?" 40 : 686-697, 2016

33 Sheron N, "Alcohol and liver disease in Europe—Simple measures have the potential to prevent tens of thousands of premature deaths" 64 : 957-967, 2016

34 Singal AK, "ACG clinical guideline:Alcoholic liver disease" 113 : 175-194, 2018

35 Shih FS, "A single NF-jB system for both canonical and non-canonical signaling" 21 : 86-102, 2011